Difficulty: Medium
Average Score: 75%
Practice
Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin:
Correct answer
B
Rationale
Estrogen replacement therapy in menopausal women has been associated with an increased risk of endometrial carcinoma due to unopposed estrogen stimulation. Adding a progestin for 10-12 days each month helps to counteract this risk by providing progestational support, which protects the endometrium from estrogen-induced hyperplasia and potential malignant transformation. This combination therapy is known as hormone replacement therapy and is commonly recommended to reduce the risk of endometrial carcinoma in menopausal women receiving estrogen therapy.